Effect Of Ayurvedic Medicine In Piles.

Phase 2

Not yet recruiting

• Conditions: Second degree hemorrhoids. Ayurveda Condition: ARSAH,

• Registration Number: CTRI/2025/03/082398
• Lead Sponsor: Gaurav Umesh Sachdev

Brief Summary

This study is a randomized open labelled controlled clinical trial comparing the safety and efficacy of Patrakadi Vati 250 mg and controlled Arshoghani Vati 300 mg for 28 days in 80 patients with first and second degree internal haemorrhoids.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-01-04
• Last Update Posted: 2025-03-14

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• 1.Patients of age group 18 to 50 years.
• 2.Patients of both genders are accepted.
• 3.Patients diagnosed with Abhayantar Arsha [First and Second degree Haemorrhoids) will be selected.
• 5.Individuals experiencing Haemorrhoidal symptom (pain, bleeding prolapse) for atleast 4 weeks.

Exclusion Criteria

• 1.Patient with Haemoglobin less than 8gm%.
• 2.With known case of 3rd an 4th degree hemorrhoids,fissure,fistula,prolapsed rectum.
• 3.Patient with severe systemic illness such as HTN,Uncontrolled DM,CVD and HIV and Immunocompromised patients.
• 4.Pregnant And lactating mother.
• Patients with active gastrointestinal disease Such as UC,CD,CA.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of this study is to assess the efficacy of oral administration of 250mg Patrakadi Vati with Gudodak twice daily for 28 days in managing Abhyantar Arsha (First and Second Degree Internal Hemorrhoids) by evaluating:	0,7th,14th and 28th Day
Reduction in bleeding episodes,	0,7th,14th and 28th Day
Improvement in constipation,	0,7th,14th and 28th Day
Decrease in anal pain,	0,7th,14th and 28th Day
Regression in pile mass size and number.	0,7th,14th and 28th Day

Secondary Outcome Measures

Name	Time	Method
1.Duration of symptom relief (pain, constipation, pile mass regression) ,assessed on Day 7, Day 14, & Day 28.	2.Reduction in bleeding episodes measured by frequency & severity of hemorrhoidal bleeding on Day 7, Day 14, & Day 28.

Trial Locations

Locations (1)

Siddhakala Ayurved Mahavidyalay,Sangamner; 🇮🇳 Ahmadnagar, MAHARASHTRA, India

Siddhakala Ayurved Mahavidyalay,Sangamner

🇮🇳Ahmadnagar, MAHARASHTRA, India

Dr Gaurav Umesh Sachdev

Principal investigator

8552024074

drgauravsachdev7@gmail.com